Korean startup Medipal expands into Vietnam’s $2.5B digital health market with its post-treatment SaaS platform, Afterdoc—via partnership with H+ Yangji Hospital.
#HealthTech #KoreanStartups #Medipal #Afterdoc #DigitalHealth #SaaS
www.koreatechdesk.com/korean-start...
#HealthTech #KoreanStartups #Medipal #Afterdoc #DigitalHealth #SaaS
www.koreatechdesk.com/korean-start...
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS - KoreaTechDesk | Korean Startup and Technology News
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion digit...
www.koreatechdesk.com
July 30, 2025 at 4:05 AM
Korean startup Medipal expands into Vietnam’s $2.5B digital health market with its post-treatment SaaS platform, Afterdoc—via partnership with H+ Yangji Hospital.
#HealthTech #KoreanStartups #Medipal #Afterdoc #DigitalHealth #SaaS
www.koreatechdesk.com/korean-start...
#HealthTech #KoreanStartups #Medipal #Afterdoc #DigitalHealth #SaaS
www.koreatechdesk.com/korean-start...
Drug wholesaler Medipal Holdings is seeking merger and acquisition opportunities to diversify its business and combat slower growth in the market in Japan.
Medipal seeks to diversify amid falling drug margins
Japan’s largest drug wholesaler is seeking to boost profit, excluding extraordinary items, to ¥100 billion by March 2027 from ¥65 billion in the latest fiscal year.
www.japantimes.co.jp
July 1, 2025 at 1:17 PM
Drug wholesaler Medipal Holdings is seeking merger and acquisition opportunities to diversify its business and combat slower growth in the market in Japan.
Sponsored: How one IPC lead saved the equivalent of three band 5 salaries
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care. #infections
www.nursingtimes.net/infection-pr...
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care. #infections
www.nursingtimes.net/infection-pr...
IPC lead saves trust three band 5 salaries with switch to Medipal products
An NHS trust has unlocked annual savings equivalent to the salaries of up to three band 5 nurses after making what has been described as an ‘effortless’
www.nursingtimes.net
August 24, 2026 at 1:02 PM
Sponsored: How one IPC lead saved the equivalent of three band 5 salaries
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care. #infections
www.nursingtimes.net/infection-pr...
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care. #infections
www.nursingtimes.net/infection-pr...
How one IPC lead saved the equivalent of three band 5 salaries
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care.
Read the full case study
www.nursingtimes.net/infection-pr...
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care.
Read the full case study
www.nursingtimes.net/infection-pr...
IPC lead saves trust three band 5 salaries with switch to Medipal products
An NHS trust has unlocked annual savings equivalent to the salaries of up to three band 5 nurses after making what has been described as an ‘effortless’
www.nursingtimes.net
July 6, 2026 at 3:52 PM
How one IPC lead saved the equivalent of three band 5 salaries
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care.
Read the full case study
www.nursingtimes.net/infection-pr...
Discover how an NHS trust achieved annual savings of up to £80,000 while simplifying infection prevention processes and giving clinical staff more time for patient care.
Read the full case study
www.nursingtimes.net/infection-pr...
🧵 Le taux directeur japonais atteint 1,25 % — la réévaluation discrète de Medipal met à l'épreuve la poussée de Tokyo sur la gouvernance
September 19, 2026 at 7:21 PM
🧵 Le taux directeur japonais atteint 1,25 % — la réévaluation discrète de Medipal met à l'épreuve la poussée de Tokyo sur la gouvernance
🧵 Il tasso di riferimento giapponese tocca l'1,25% — il silenzioso rerating di Medipal mette alla prova la spinta di Tokyo sulla governance
September 19, 2026 at 7:22 PM
🧵 Il tasso di riferimento giapponese tocca l'1,25% — il silenzioso rerating di Medipal mette alla prova la spinta di Tokyo sulla governance
🧵 El tipo oficial de Japón alcanza el 1,25%: la discreta revalorización de Medipal pone a prueba el impulso de gobernanza de Tokio
September 19, 2026 at 7:22 PM
🧵 El tipo oficial de Japón alcanza el 1,25%: la discreta revalorización de Medipal pone a prueba el impulso de gobernanza de Tokio
September 2026, dass die Medipal-Aktien an der Tokioter Börse leicht zulegten, während Investoren weiterhin die im Mai 2026 veröffentlichten Geschäftszahlen des Konzerns für das Fiskaljahr 2025 verarbeiteten; das Papier notiert inzwischen in moderater Reichweite seines
September 19, 2026 at 7:20 PM
September 2026, dass die Medipal-Aktien an der Tokioter Börse leicht zulegten, während Investoren weiterhin die im Mai 2026 veröffentlichten Geschäftszahlen des Konzerns für das Fiskaljahr 2025 verarbeiteten; das Papier notiert inzwischen in moderater Reichweite seines
Ad Hoc News ha riferito il 19 settembre 2026 che le azioni Medipal sulla Borsa di Tokyo sono salite leggermente, mentre gli investitori continuano a metabolizzare i risultati dell'esercizio fiscale 2025 del gruppo, pubblicati a maggio 2026, con il titolo che ora tratta entro
September 19, 2026 at 7:22 PM
Ad Hoc News ha riferito il 19 settembre 2026 che le azioni Medipal sulla Borsa di Tokyo sono salite leggermente, mentre gli investitori continuano a metabolizzare i risultati dell'esercizio fiscale 2025 del gruppo, pubblicati a maggio 2026, con il titolo che ora tratta entro
Ad Hoc News a rapporté le 19 septembre 2026 que l'action Medipal, cotée à la Bourse de Tokyo, progressait légèrement, les investisseurs continuant d'assimiler les résultats de l'exercice 2025 du groupe, publiés en mai 2026, le titre évoluant désormais dans une fourchette
September 19, 2026 at 7:21 PM
Ad Hoc News a rapporté le 19 septembre 2026 que l'action Medipal, cotée à la Bourse de Tokyo, progressait légèrement, les investisseurs continuant d'assimiler les résultats de l'exercice 2025 du groupe, publiés en mai 2026, le titre évoluant désormais dans une fourchette
Ad Hoc News informó el 19 de septiembre de 2026 de que las acciones de Medipal en la Bolsa de Tokio subieron ligeramente mientras los inversores seguían digiriendo los resultados del ejercicio fiscal 2025 del grupo, publicados en mayo de 2026, con el valor cotizando ahora
September 19, 2026 at 7:22 PM
Ad Hoc News informó el 19 de septiembre de 2026 de que las acciones de Medipal en la Bolsa de Tokio subieron ligeramente mientras los inversores seguían digiriendo los resultados del ejercicio fiscal 2025 del grupo, publicados en mayo de 2026, con el valor cotizando ahora
Ad Hoc News reported on September 19, 2026 that Medipal shares on the Tokyo Stock Exchange edged higher as investors continued to digest the group's fiscal 2025 results, published back in May 2026, with the stock now trading within a moderate range of its 52-week high.
September 19, 2026 at 7:20 PM
Ad Hoc News reported on September 19, 2026 that Medipal shares on the Tokyo Stock Exchange edged higher as investors continued to digest the group's fiscal 2025 results, published back in May 2026, with the stock now trading within a moderate range of its 52-week high.
Clinical Trial Commences for JR-446 in Treating MPS IIIB Condition#Japan#Chūō_City#JR-446#MPS_IIIB#J-Brain_Cargo
Clinical Trial Commences for JR-446 in Treating MPS IIIB Condition
MediPal Holdings and JCR Pharma announce the start of the global clinical trial for JR-446, targeting the rare condition MPS IIIB.
third-news.com
September 11, 2026 at 1:41 AM
Clinical Trial Commences for JR-446 in Treating MPS IIIB Condition#Japan#Chūō_City#JR-446#MPS_IIIB#J-Brain_Cargo
JLSW Daily Brief #092 (Sep 9): Kyowa Kirin's anti-VEGF eye drop KHK4951 misses primary endpoint in nAMD Ph2. Medipal names new CEO after 14 yrs. Novo halts 2 more heart trials.
#KyowaKirin #NovoNordisk #LifeSciencesJapan
https://jlsweekly.substack.com/p/vegfkhk4951p2novo-nordisk2
#KyowaKirin #NovoNordisk #LifeSciencesJapan
https://jlsweekly.substack.com/p/vegfkhk4951p2novo-nordisk2
September 8, 2026 at 9:16 PM
JLSW Daily Brief #092 (Sep 9): Kyowa Kirin's anti-VEGF eye drop KHK4951 misses primary endpoint in nAMD Ph2. Medipal names new CEO after 14 yrs. Novo halts 2 more heart trials.
#KyowaKirin #NovoNordisk #LifeSciencesJapan
https://jlsweekly.substack.com/p/vegfkhk4951p2novo-nordisk2
#KyowaKirin #NovoNordisk #LifeSciencesJapan
https://jlsweekly.substack.com/p/vegfkhk4951p2novo-nordisk2
Medipal Holdings Releases Integrated Report 2026 for Stakeholder Insight#Japan#Tokyo#Integrated_Report#Medipal_Holdings#PALTAC
Medipal Holdings Releases Integrated Report 2026 for Stakeholder Insight
Medipal Holdings recently launched its Integrated Report 2026, offering insights into its corporate strategies and sustainable value creation.
third-news.com
August 28, 2026 at 1:50 AM
Medipal Holdings Releases Integrated Report 2026 for Stakeholder Insight#Japan#Tokyo#Integrated_Report#Medipal_Holdings#PALTAC
Medipal Group Enhances Order-epi® with New Inventory Features for Healthcare Providers#Japan#healthcare#Tokyo#Order-epi®#Medipal_Group
Medipal Group Enhances Order-epi® with New Inventory Features for Healthcare Providers
Medipal Group has introduced new features to its Order-epi® web ordering system, enhancing inventory visibility for healthcare providers.
third-news.com
August 28, 2026 at 1:51 AM
Medipal Group Enhances Order-epi® with New Inventory Features for Healthcare Providers#Japan#healthcare#Tokyo#Order-epi®#Medipal_Group
Mitsubishi Corporation and Medipal Holdings Forge New Healthcare Partnership#Japan#healthcare#Tokyo#Medipal_Holdings#Mitsubishi_Corp
Mitsubishi Corporation and Medipal Holdings Forge New Healthcare Partnership
Mitsubishi Corporation and Medipal Holdings have entered a new partnership focused on healthcare, food, and daily necessities, enhancing their collaborative efforts.
third-news.com
August 7, 2026 at 1:46 AM
Mitsubishi Corporation and Medipal Holdings Forge New Healthcare Partnership#Japan#healthcare#Tokyo#Medipal_Holdings#Mitsubishi_Corp
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Well Being Market With Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Well Being Market With Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly rising $2.5 billion digital well being market. The settlement marks not solely Medipal’s first worldwide deployment but additionally a notable milestone within the world growth of South Korea’s digital healthcare ecosystem. Medipal and H+ Yangji Hospital Partnership: First Abroad Market Enlargement in Digital Healthcare Korean healthtech startup Medipal has formally launched its first abroad growth into Vietnam’s quickly rising digital healthcare sector by means of a strategic provide settlement with…
nextbusiness24.com
July 31, 2025 at 9:22 PM
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Well Being Market With Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion digital health market. The agreement marks not only Medipal’s first international deployment but also a notable milestone in the global expansion of South Korea’s digital healthcare ecosystem. Medipal and H+ Yangji Hospital Partnership: First Overseas Market Expansion in Digital Healthcare…
nexttech-news.com
July 31, 2025 at 9:17 PM
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Medipal Holdings Corp. Annual meeting (2026-06-24) - NBIM voted against management:
• Against Management proposal: Elect Director Watanabe,…
See full meeting details.
• Against Management proposal: Elect Director Watanabe,…
See full meeting details.
June 19, 2026 at 4:40 PM
Medipal Holdings Corp. Annual meeting (2026-06-24) - NBIM voted against management:
• Against Management proposal: Elect Director Watanabe,…
See full meeting details.
• Against Management proposal: Elect Director Watanabe,…
See full meeting details.
Travel horror story: Man describes malaria coma, $30K hospital bill after brief trip to Uganda
Travel horror story: Man describes malaria coma, $30K hospital bill after brief trip to Uganda
A man from Alberta has been at the Medipal International Hospital in Kampala, Uganda for over two months with a hefty medical bill. He says he can’t leave until it’s been paid for.
www.ctvnews.ca
September 27, 2024 at 10:52 AM
Travel horror story: Man describes malaria coma, $30K hospital bill after brief trip to Uganda
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion digital health market. The agreement marks not only Medipal’s first international deployment but also a notable milestone in the global expansion of South Korea’s digital healthcare ecosystem. Medipal and H+ Yangji Hospital Partnership: First Overseas Market Expansion in Digital Healthcare…
nexttech-news.com
July 31, 2025 at 9:16 PM
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Health Market with Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean healthtech startup Medipal has entered into a strategic partnership with H+ Yangji Hospital to expand its patient care SaaS platform, Afterdoc, into Vietnam’s rapidly growing $2.5 billion…
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Well Being Market With Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Well Being Market With Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly rising $2.5 billion digital well being market. The settlement marks not solely Medipal’s first worldwide deployment but additionally a notable milestone within the world growth of South Korea’s digital healthcare ecosystem. Medipal and H+ Yangji Hospital Partnership: First Abroad Market Enlargement in Digital Healthcare Korean healthtech startup Medipal has formally launched its first abroad growth into Vietnam’s quickly rising digital healthcare sector by means of a strategic provide settlement with…
nextbusiness24.com
July 31, 2025 at 9:22 PM
Korean Startup Medipal Enters Vietnam’s $2.5B Digital Well Being Market With Afterdoc SaaS – KoreaTechDesk
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…
Korean healthtech startup Medipal has entered right into a strategic partnership with H+ Yangji Hospital to broaden its affected person care SaaS platform, Afterdoc, into Vietnam’s quickly…